{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:48:04Z","timestamp":1787006884294,"version":"build-2736575974"},"reference-count":13,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T00:00:00Z","timestamp":1266451200000},"content-version":"vor","delay-in-days":463,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2008,11,12]]},"abstract":"<jats:p>Despite the high numbers of veterans with opioid dependence, few receive pharmacologic treatment for this disorder. The adoption of buprenorphine treatment within the Veterans Health Administration (VHA) has been slow. To expand capacity for buprenorphine treatment, the VHA sponsored two eight\u2010hour credentialing courses for the Drug Addiction Treatment Act of 2000. We sought to describe the outcomes of such training. Following the training sessions, 29 participants (18 physicians) were highly satisfied with course content and affirmed their intention to prescribe buprenorphine; after nine\u2010month follow\u2010up, two physicians were prescribing. We conclude that providing credentialing courses, while popular, did not markedly promote the prescription of buprenorphine.<\/jats:p>","DOI":"10.1080\/10550490802408613","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T08:49:12Z","timestamp":1227689352000},"page":"459-462","source":"Crossref","is-referenced-by-count":34,"title":["Outcomes of DATA 2000 Certification Trainings for the Provision of Buprenorphine Treatment in the Veterans Health Administration"],"prefix":"10.1111","volume":"17","author":[{"given":"Adam J.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Liberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Granda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Salmon\u2010Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tykia","family":"Andr\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"McNicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.03.010"},{"key":"e_1_2_6_3_2","unstructured":"GoodmanF GordonA KivlahanDet al.Criteria for use of buprenophine\/naloxone and Buprenorphine sublingual tabletsAvailable at:http:\/\/www.pbm.va.gov\/criteria\/BuprenorphineCriteriaForUse.pdfAccessed October 1 2007."},{"key":"e_1_2_6_4_2","unstructured":"Drug Addiction Treatment Act of 2000.42 USC\u00a7 3502a."},{"key":"e_1_2_6_5_2","unstructured":"StantonA McLeodC LuckeyBet al.SAMHSA\/CSAT evaluation of the buprenorphine waiver program. Expanding treatment of opioid dependence: Initial physician and patient experiences with the adoption of buprenorphineAvailable at:http:\/\/buprenor\u2010phine.samhsa.gov\/ASAM_06_Final_Results.pdf. Accessed December 5 2006."},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n04_09"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1300\/J465v27n03_06"},{"key":"e_1_2_6_8_2","unstructured":"KleberH.Differential patterns of buprenorphine use in the U.S. presentation at the 2008 American Psychiatric AssociationMay 5 2008 Washington D.C.."},{"key":"e_1_2_6_9_2","unstructured":"RennerJA.Presentation at the 2008 Buprenorphine in the Treatment of Opioid Addiction: Expanding Access\u2010Enhancing Quality (2008 Buprenorphine Summit): Education status report: Successes & challengesWashington D.C..February 21 2008."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1300\/J465v25n04_05"},{"key":"e_1_2_6_11_2","volume-title":"Transferring Learning to Behavior","author":"Kirkpatrick DL","year":"2005"},{"key":"e_1_2_6_12_2","volume-title":"How to Measure Training Results","author":"Phillips JJ","year":"2002"},{"key":"e_1_2_6_13_2","unstructured":"McNicholasLF GordonAJ KaneV LoweJ SinghG.Buprenorphine in the treatment of opiate dependence: A network\u2010wide initiative.Poster presentation at the 2005 Best Practices in VHA Mental Healthcare SystemsMesa Ariz..October 2005."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp013579"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F10550490802408613","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/10550490802408613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:43:19Z","timestamp":1698730999000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1080\/10550490802408613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,12]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11,12]]}},"alternative-id":["10.1080\/10550490802408613"],"URL":"https:\/\/doi.org\/10.1080\/10550490802408613","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,12]]}}}